NCT04342572View on ClinicalTrials.gov

Intra-arterial Chemotherapy for Retinoblastoma

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

August 11, 2020

Primary Completion Date

January 4, 2023

Study Completion Date

March 21, 2025

Conditions
Retinoblastoma
Interventions
DRUG

Melphalan

-The drug is commerically available

Trial Locations (1)

63110

Washington University School of Medicine (Saint Louis Children's Hospital), St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT04342572 - Intra-arterial Chemotherapy for Retinoblastoma | Biotech Hunter | Biotech Hunter